Focus on Diabetes Care

Back to articles

Intensive glucose control: Surprising benefits for heart disease

KEY POINT

Data from a new post hoc analysis of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial suggest that intensive glycemic control may be associated with a 15%–20% reduction in the risk of myocardial infarction (MI), unstable angina, and coronary revascularization.

SOURCES

Gerstein HC et al. Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial. The Lancet. 2014;Aug. 1[Epub ahead of print].

 Chiasson JL et al. Glycaemic control, cardiovascular disease, and mortality in type 2 diabetes. The Lancet. 2014;Aug. 1[Epub ahead of print].